Biochemistry
-
Extracellular Vesicles Analysis in the COVID-19 Era: Insights on Serum Inactivation Protocols Towards Downstream Isolation and Analysis
This article has 12 authors:Reviewed by ScreenIT
-
In vitro measurements of protein–protein interactions show that antibody affinity governs the inhibition of SARS-CoV-2 spike/ACE2 binding in convalescent serum
This article has 12 authors:Reviewed by ScreenIT
-
A Pan-Respiratory Antiviral Chemotype Targeting a Host Multi-Protein Complex
This article has 57 authors:Reviewed by ScreenIT
-
Protonation states in SARS-CoV-2 main protease mapped by neutron crystallography
This article has 8 authors:Reviewed by ScreenIT
-
The repurposed drugs suramin and quinacrine inhibit cooperatively in vitro SARS-CoV-2 3CL pro
This article has 6 authors:Reviewed by ScreenIT
-
Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design
This article has 10 authors:Reviewed by ScreenIT
-
Conformational diversity of CDR region during affinity maturation determines the affinity and stability of Sars-Cov-1 VHH-72 nanobody
This article has 1 author:Reviewed by ScreenIT
-
Remdesivir is a delayed translocation inhibitor of SARS CoV-2 replication in vitro
This article has 4 authors:Reviewed by ScreenIT
-
Designed variants of ACE2-Fc that decouple anti-SARS-CoV-2 activities from unwanted cardiovascular effects
This article has 4 authors:Reviewed by ScreenIT
-
High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
This article has 5 authors:Reviewed by ScreenIT